Picropodophyllotoxin or podophyllotoxin does not induce cell death via insulin-like growth factor-I receptor [1]

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2899-

  Linder, Stig ^a   Shoshan, Maria C ^a   Gupta, Radhey S ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; DEMECOLCINE; LIGNAN DERIVATIVE; PICROPODOPHYLLIN; PODOPHYLLOTOXIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VINBLASTINE;

CANCER THERAPY; CELL CYCLE ARREST; CELL DEATH; CELL TYPE; CELL VIABILITY; CONCENTRATION RESPONSE; CONDYLOMA; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; DRUG TARGETING; GROWTH INHIBITION; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNSPECIFIED SIDE EFFECT;

ANIMALS; CELL DEATH; FIBROBLASTS; MICE; PODOPHYLLOTOXIN; RECEPTOR, IGF TYPE 1;

EID: 34047270772     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0635     Document Type: Letter

References (5)

1. Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res 2004;64:236-42.
2. Cortese F, Bhattacharyya B, Wolff J. Podophyllotoxin as a probe for the colchicine binding site of tubulin. J Biol Chem 1977;252:1134-40.
3. Gupta RS. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues. Cancer Res 1983;43:505-12.
4. Loike JD, Brewer CF, Sternlicht H, Gensler WJ, Horwitz SB. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Res 1978;38:2688-93.
5. 2-M-phase accumulation and apoptosis in multiple myeloma cells. Blood 2006;107:669-78.